Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Birth Defects Research. Part A, Clinical and Molecular Teratology|August 2, 2007
Selection of controls in case-control studies on maternal medication use and risk of birth defectsMarian K Bakker, Hermien E K de Walle, Aileen Dequito, et al.
British Journal of Clinical Pharmacology|October 24, 2007
Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the NetherlandsMarian K Bakker, Pieternel Kölling, Paul B van den Berg, et al.
Acta Paediatrica (Oslo, Norway : 1992)|April 29, 2009
Antibiotic usage, dosage and course length in children between 0 and 4 yearsJosta de Jong, Paul B van den Berg, Sipke T Visser, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation informationEric Schirm, Taco B M Monster, Robin de Vries, et al.
Pharmacoepidemiology and Drug Safety|October 20, 2007
Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive studyFokaline Vroom, Eric N van Roon, Paul B van den Berg, et al.
Journal of Clinical Psychopharmacology|November 18, 2008
Predictors for starting depot administration of risperidone in chronic users of antipsychoticsJelle Vehof, Maarten J Postma, Richard Bruggeman, et al.
Psychiatric Services (Washington, D.C.)|May 3, 2008
Use of antipsychotic drugs among Dutch youths between 1997 and 2005Luuk J Kalverdijk, Hilde Tobi, Paul B van den Berg, et al.
Helicobacter|May 26, 2004
Pharmacoeconomics of gastrointestinal drug utilisation prior and post Helicobacter pylori eradicationRogier M Klok, Willem Jan van der Veen, Ger Th van der Werf, et al.
Applied Health Economics and Health Policy|November 29, 2005
Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine: a study conducted for the NetherlandsCornelis Boersma, Rogier M Klok, Jasper M Bos, et al.
Pageof 2